164 related articles for article (PubMed ID: 26373808)
1. Frequent activation of the β-catenin gene in sporadic colorectal carcinomas: A mutational & expression analysis.
Anwar M; Kochhar R; Singh R; Bhatia A; Vaiphei K; Mahmood A; Mahmood S
Mol Carcinog; 2016 Nov; 55(11):1627-1638. PubMed ID: 26373808
[TBL] [Abstract][Full Text] [Related]
2. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
3. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
Breuhahn K; Singh S; Schirmacher P; Bläker H
J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
[TBL] [Abstract][Full Text] [Related]
4. TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans.
Anwar M; Malhotra P; Kochhar R; Bhatia A; Mahmood A; Singh R; Mahmood S
Cell Mol Biol Lett; 2020; 25():24. PubMed ID: 32265994
[TBL] [Abstract][Full Text] [Related]
5. β-Catenin accumulation and S33F mutation of CTNNB1 gene in colorectal cancer in Saudi Arabia.
Alomar SY; Mansour L; Abuderman A; Alkhuriji A; Arafah M; Alwasel S; Harrath AH; Almutairi M; Trayhyrn P; Dar JA
Pol J Pathol; 2016 Jun; 67(2):156-62. PubMed ID: 27543871
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of the immunohistochemical expression and mutational pattern of the key mediator of Wnt signaling: beta-catenin in Tunisian patients with colorectal carcinoma.
Khiari M; Arfaoui A; Kriaa L; Chaar I; Amara S; Lounis MA; Sammoud S; Dhraeif M; Gharbi L; Mzabi-Regaya S; Bouraoui S
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):62-70. PubMed ID: 21602666
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of selenomethionine on carcinogenesis in the model of human colorectal cancer in vitro and its link to the Wnt/β-catenin pathway.
Korbut E; Ptak-Belowska A; Brzozowski T
Acta Biochim Pol; 2018; 65(3):359-366. PubMed ID: 30016378
[TBL] [Abstract][Full Text] [Related]
8. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
[TBL] [Abstract][Full Text] [Related]
9. Expression and mutation pattern of β-catenin and adenomatous polyposis coli in colorectal cancer patients.
Abdelmaksoud-Damak R; Miladi-Abdennadher I; Triki M; Khabir A; Charfi S; Ayadi L; Frikha M; Sellami-Boudawara T; Mokdad-Gargouri R
Arch Med Res; 2015 Jan; 46(1):54-62. PubMed ID: 25660336
[TBL] [Abstract][Full Text] [Related]
10. [Real-time PCR analysis of beta-catenin mRNA in sporadic colorectal cancers].
Qin YJ; Zhou XY; Cai SJ; Yan G; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):535-9. PubMed ID: 17134547
[TBL] [Abstract][Full Text] [Related]
11.
Fredericks E; Dealtry G; Roux S
Can J Gastroenterol Hepatol; 2018; 2018():4379673. PubMed ID: 30186819
[TBL] [Abstract][Full Text] [Related]
12. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
13. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
15. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
17. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
18. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
19. The majority of β-catenin mutations in colorectal cancer is homozygous.
Arnold A; Tronser M; Sers C; Ahadova A; Endris V; Mamlouk S; Horst D; Möbs M; Bischoff P; Kloor M; Bläker H
BMC Cancer; 2020 Oct; 20(1):1038. PubMed ID: 33115416
[TBL] [Abstract][Full Text] [Related]
20. Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.
Lüchtenborg M; Weijenberg MP; Wark PA; Saritas AM; Roemen GM; van Muijen GN; de Bruïne AP; van den Brandt PA; de Goeij AF
BMC Cancer; 2005 Dec; 5():160. PubMed ID: 16356174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
